Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 24;23(1):489.
doi: 10.1186/s12879-023-08468-6.

Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019)

Julia E Marshall  1 , Rachel A Mercaldo  2 , Ettie M Lipner  2 , D Rebecca Prevots  2
Affiliations

Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019)

Julia E Marshall et al. BMC Infect Dis. .

Abstract

Background: Nontuberculous mycobacteria (NTM) are ubiquitous, environmental bacteria that can cause chronic lung disease. Persons with cystic fibrosis (pwCF) are at high risk for NTM. Approximately 1 in 5 pwCF in the United States (U.S.) is affected by pathogenic NTM species, and incidence rates of NTM have been increasing among pwCF as well as in the general population. Prevalence of NTM pulmonary infections (PI) varies widely across the United States because of geographic variation in environmental exposures. This study will present updated region-level incidence of NTM infections in the cystic fibrosis (CF) population in the U.S.

Methods: We used the Cystic Fibrosis Foundation Patient Registry (CFFPR) data for the period 2010 through 2019. Our study population comprised persons with CF ≥ 12 years of age who had been tested for NTM PI. We included only registry participants with NTM culture results. We defined incident cases as persons with one positive mycobacterial culture preceded by ≥ two negative mycobacterial cultures. We defined non-cases as persons with ≥ two negative mycobacterial cultures. We estimated average annual NTM PI incidence by region. Using quasi-Poisson models, we calculated annual percent change in incidence by region.

Results: We identified 3,771 incident NTM infections. Of these cases, 1,816 (48.2%) were Mycobacterium avium complex (MAC) infections and 960 (25.5%) were Mycobacterium abscessus infections. The average annual incidence of NTM PI among pwCF in the U.S. was 58.0 cases per 1,000 persons. The Northeast had the highest incidence of MAC (33.5/1,000 persons tested) and the South had the highest incidence of M. abscessus (20.3/1,000 persons tested). From 2010 to 2019, the annual incidence of total NTM PI increased significantly by 3.5% per year in the U.S.

Conclusions: NTM PI incidence is increasing among pwCF. Identifying high risk areas and increasing trends is important for allocating public health and clinical resources as well as evaluating interventions.

Keywords: Cystic fibrosis; Incident infections; Mycobacterium abscessus; Mycobacterium avium complex; Nontuberculous mycobacteria; Pulmonary infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
(a) Map of MAC average incidence (per 1,000 persons with CF tested) by region (2010–2019). Color categories represent data quantiles.; (b) Map of M. abscessus average annual incidence (per 1,000 persons with CF tested) by region (2010–2019). Color categories represent data quantiles
Fig. 2
Fig. 2
a) Annual Incidence of MAC PI by U.S. Region (2010–2019). b) Annual Incidence of M. abscessus PI by U.S. Region (2010–2019). *Significant annual percent change (p<0.05)
See this image and copyright information in PMC

References

    1. Dean SG, Ricotta EE, Fintzi J, Lai YL, Kadri SS, Olivier KN, et al. Mycobacterial testing Trends, United States, 2009–2015(1) Emerg Infect Dis. 2020;26(9):2243–6. doi: 10.3201/eid2609.200749. - DOI - PMC - PubMed
    1. Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of Nontuberculous Mycobacterial Lung Disease in a large U.S. Managed Care Health Plan, 2008–2015. Ann Am Thorac Soc. 2020;17(2):178–85. doi: 10.1513/AnnalsATS.201804-236OC. - DOI - PMC - PubMed
    1. Adjemian J, Olivier KN, Prevots DR. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum positivity in patients with cystic fibrosis in the United States, 2010–2014. Annals of the American Thoracic Society. 2018;15(7):817–26. doi: 10.1513/AnnalsATS.201709-727OC. - DOI - PMC - PubMed
    1. Esther CR, Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros. 2010;9(2):117–23. doi: 10.1016/j.jcf.2009.12.001. - DOI - PMC - PubMed
    1. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003;167(6):835–40. doi: 10.1164/rccm.200207-679OC. - DOI - PubMed

MeSH terms